Plasma and salivary pharmacokinetics of caffeine in man
- PMID: 7333346
- DOI: 10.1007/BF00609587
Plasma and salivary pharmacokinetics of caffeine in man
Abstract
Plasma and salivary caffeine concentrations were measured by gas-liquid chromatography in 6 healthy caffeine-free volunteers following oral administration of 50, 300, 500 and 750 mg caffeine. Caffeine was also given to a single subject intravenously in doses of 300, 500 and 750 mg. Caffeine was rapidly absorbed and was completely available at all doses. The apparent first-order elimination rate constant decreased linearly with dose and was 0.163 +/- 0.081 h-1 for 50 mg and 0.098 +/- 0.027 h-1 for 750 mg. The total body clearance was unaffected by dose and was 0.98 +/- 0.38 ml/min/kg. There was a trend towards increasing apparent volume of distribution with increasing dose. A linear relationship existed between the area under the plasma concentration, time curve and dose and dose-normalised plasma concentration, time plots were superimposable. These findings suggest that caffeine obeys linear pharmacokinetics over the dose range investigated. Despite significant inter-individual differences in pharmacokinetic parameters there was good reproducibility within 5 subjects given 300 mg caffeine orally on 3 occasions. Salivary caffeine levels probably reflect the unbound plasma caffeine concentration and can be used to estimate the pharmacokinetic parameters of the drug. Overall the saliva/plasma concentration ratio was 0.74 +/- 0.08 but within subjects some time-dependence of the ratio was found with higher ratios initially (even after intravenous administration) and lower ratios at longer time intervals after the dose. Urinary elimination of caffeine was low and independent of dose: 1.83% of the dose was eliminated unchanged.
Similar articles
-
Relationship between caffeine concentrations in plasma and saliva.Clin Pharmacol Ther. 1984 Jul;36(1):133-7. doi: 10.1038/clpt.1984.151. Clin Pharmacol Ther. 1984. PMID: 6734043
-
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.Eur J Clin Pharmacol. 2000 May;56(2):159-65. doi: 10.1007/s002280050735. Eur J Clin Pharmacol. 2000. PMID: 10877011 Clinical Trial.
-
The absolute bioavailability of caffeine in man.Eur J Clin Pharmacol. 1983;24(1):93-8. doi: 10.1007/BF00613933. Eur J Clin Pharmacol. 1983. PMID: 6832208 Clinical Trial.
-
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001. Clin Pharmacokinet. 1976. PMID: 13958 Review.
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
Cited by
-
Acute ingestion of caffeinated chewing gum reduces fatigue index and improves 400-meter performance in trained sprinters: a double-blind crossover trial.J Int Soc Sports Nutr. 2024 Dec;21(1):2414871. doi: 10.1080/15502783.2024.2414871. Epub 2024 Oct 10. J Int Soc Sports Nutr. 2024. PMID: 39390816 Free PMC article. Clinical Trial.
-
Caffeine ingestion compromises thermoregulation and does not improve cycling time to exhaustion in the heat amongst males.Eur J Appl Physiol. 2024 Aug;124(8):2489-2502. doi: 10.1007/s00421-024-05460-z. Epub 2024 Apr 3. Eur J Appl Physiol. 2024. PMID: 38568259 Free PMC article. Clinical Trial.
-
The Influence of Coffee on Reducing Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes: A Review.Cureus. 2023 Dec 7;15(12):e50118. doi: 10.7759/cureus.50118. eCollection 2023 Dec. Cureus. 2023. PMID: 38192918 Free PMC article. Review.
-
Determination of Gastric Water Emptying in Fasted and Fed State Conditions Using a Compression-Coated Tablet and Salivary Caffeine Kinetics.Pharmaceutics. 2023 Nov 4;15(11):2584. doi: 10.3390/pharmaceutics15112584. Pharmaceutics. 2023. PMID: 38004563 Free PMC article.
-
Potential Benefits of Coffee Consumption on Improving Biomarkers of Oxidative Stress and Inflammation in Healthy Individuals and Those at Increased Risk of Cardiovascular Disease.Molecules. 2023 Sep 5;28(18):6440. doi: 10.3390/molecules28186440. Molecules. 2023. PMID: 37764216 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
